CC BY-NC-ND 4.0 · Journal of Child Science 2017; 07(01): e127-e129
DOI: 10.1055/s-0037-1607237
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Pseudohypoaldosteronism Type 1—An Exercise in Clinical Deduction and Critical Management

Meenakshi Girish
1   Department of Pediatrics, NKP Salve Institute of Medical Sciences & Research Center, Nagpur, Maharashtra, India
,
Pradeep Pazare
1   Department of Pediatrics, NKP Salve Institute of Medical Sciences & Research Center, Nagpur, Maharashtra, India
,
Archana Jaiswal
1   Department of Pediatrics, NKP Salve Institute of Medical Sciences & Research Center, Nagpur, Maharashtra, India
,
Yash Banait
1   Department of Pediatrics, NKP Salve Institute of Medical Sciences & Research Center, Nagpur, Maharashtra, India
,
Richa Kumar
1   Department of Pediatrics, NKP Salve Institute of Medical Sciences & Research Center, Nagpur, Maharashtra, India
› Author Affiliations
Further Information

Publication History

13 July 2017

02 September 2017

Publication Date:
28 November 2017 (online)

Abstract

Pseudohypoaldosteronism type 1 (PHA1) is a life-threatening disorder for two reasons, first because it causes severe hyperkalemia and second because the rarity of the disorder means that diagnosis is often delayed due to the lack of clinician familiarity with this condition. In this case report, we have described how even to an unsuspecting mind and eye, a systematic approach can lead to reversal of the severe hyperkalemia and arrive at the diagnosis of PHA1 as a cause of hyperkalemia. Long-term management can be successful only with dedicated care, and the prognosis is unfortunately worsened by the lack of availability of sodium-K resin in many countries, including India.

Authors' Contributions

M.G. and R.K. were responsible for case management and writing the article, Y.B. helped in reviewing the literature and discussion, and P.P. and A.J. helped in critical revision. All authors contributed toward final approval of article and take responsibility for accuracy and integrity of the work.


Funding

None.


 
  • References

  • 1 Amin N, Alvi NS, Barth JH. , et al. Pseudohypoaldosteronism type 1: clinical features and management in infancy. Endocrinol Diabetes Metab Case Rep 2013; 2013: 130010
  • 2 Arai K, Tsigos C, Suzuki Y. , et al. Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy. J Clin Endocrinol Metab 1994; 79 (04) 1019-1023
  • 3 Young WF. . Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA). In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on June 21, 2017.)
  • 4 Enuka Y, Hanukoglu I, Edelheit O, Vaknine H, Hanukoglu A. Epithelial sodium channels (ENaC) are uniformly distributed on motile cilia in the oviduct and the respiratory airways. Histochem Cell Biol 2012; 137 (03) 339-353
  • 5 Attia NA, Marzouk YI. Pseudohypoaldosteronism in a neonate presenting as life-threatening hyperkalemia. Case Rep Endocrinol 2016; 2016: 6384697
  • 6 Sharma R, Pandey M, Kanwal SK, Zennaro MC. Pseudohypoaldosteronism type 1: management issues. Indian Pediatr 2013; 50 (03) 331-333